Please login to the form below

Not currently logged in
Email:
Password:

Deloitte

This page shows the latest Deloitte news and features for those working in and with pharma, biotech and healthcare.

Orphan drugs dominate FDA's record-breaking year

Orphan drugs dominate FDA's record-breaking year

A study published in December by Deloitte showed that R&D costs have doubled in eight years, while peak sales forecasts have halved.

Latest news

  • Pharma’s R&D productivity sinks to a new low Pharma’s R&D productivity sinks to a new low

    The research by Deloitte’s Centre for Health Solutions found returns had declined 1.8 percentage points from 3.7% in 2017. ... Deloitte says the industry needs to tackle the problem with new ways of working and emphasis on finding the right talent.

  • Artificial intelligence in healthcare Artificial intelligence in healthcare

    According to a Deloitte report, AI ‘can help analyse large data sets from sources such as clinical trials, health records, genetic profiles and preclinical studies; within this data, it can recognise ... Deloitte also suggests AI can help improve study

  • NHS bracing for 'no deal’ Brexit impact, including medicines NHS bracing for 'no deal’ Brexit impact, including medicines

    According to a Deloitte survey, 75% of British companies are now pessimistic about Brexit after weak investment and waning revenues in the most recent financial quarter.

  • Health insurers will test blockchain for data handling Health insurers will test blockchain for data handling

    A Deloitte report on the application of blockchain to healthcare published in 2016 predicted that the technology could “provide a new model for health information exchanges (HIE) by making electronic medical

  • Pharma is ‘getting lower returns on R&D’ Pharma is ‘getting lower returns on R&D’

    And Deloitte says the number of drugs in late-stage trials tumbled by 16%. ... almost $2bn compared to $1.2bn in 2010 when the annual survey - by Deloitte’s Centre for Health Solutions - was first conducted.

More from news
Approximately 2 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • The Big Book of Dashboards The Big Book of Dashboards

    Steve Wexler has worked with ADP, Gallup, Deloitte, Convergys, Consumer Reports, The Economist, ConEd, D&B, Marist, Tradeweb, Tiffany, McKinsey &Company, and many other organisations to help them understand and visualise

  • The rise of real-world evidence The rise of real-world evidence

    More than half the leading life science companies polled by Deloitte in 2017 were developing or significantly improving their real-world data (RWD) capabilities.

  • A quest for innovative solutions A quest for innovative solutions

    The report from analysts Deloitte in December last year, A New Future for R&D?, highlighted diminishing revenue returns from traditional drug development models but stated: ‘We see opportunities for biopharma

  • Digitally yours: How to build effective relationships in virtual space Digitally yours: How to build effective relationships in virtual space

    It is not all about saving though. A 2015 Deloitte forecast estimates considerable growth opportunities in the global mobile and digital health market, with a forecasted rise from $2.4 billion

  • Deal Watch December 2015 Deal Watch December 2015

    December saw the release of reports by two of the top accountancy and consulting groups, PWC and Deloitte. ... Deloitte and GlobalData's report Measuring the return from pharmaceutical innovation 2015 - transforming R&D returns in uncertain times

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics